BioTelemetry, Inc. (BEAT) was a big mover last session with its shares rising roughly 7% on the day. The upside was owing to the company’s impressive net income, positive adjusted EBITDA and revenue growth results for the second quarter of 2015, announced on Aug 6, after market close. This development led to far more shares changing hands yesterday than in a normal session. The move breaks the recent trend of the company as the stock is now trading above the past one month’s volatile price range of $8.94 to $12.23.
This provider of cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services has seen one positive estimate revision in the past 30 days. The Zacks Consensus Estimate has also moved considerably higher over the same period. This implies solid trading potential for the company. So make sure to keep an eye on this stock going forward to see if Friday’s jump can turn into more strength down the road.
BioTelemetry currently has a Zacks Rank #2 (Buy).
Investors interested in the medical services industry may consider Charles River Laboratories International, Inc. (CRL) which sports a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment